This announcement is a separate document:
上海市锦天城律师事务所关于上海谊众药业股份有限公司2022年限制性股票激励计划第一个归属期符合归属条件及调整2022年限制性股票激励计划相关事项的法律意见书
Legal Opinion of Shanghai AllBright Law Firm on matters relating to the first vesting period of the 2022 Restricted Stock Incentive Plan of Shanghai Yizhong Pharmaceutical Co., Ltd. meeting the conditions of ownership and the adjustment of the 2022 Restric
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated